• VAT increases risk of all COVID-related pre-existing conditions includi

    From HeartDoc Andrew@21:1/5 to All on Mon Mar 18 01:23:07 2024
    Abstract

    Visceral adiposity is a major risk factor of cardiometabolic
    diseases.
    Visceral adipose tissue (VAT) is usually measured with expensive
    imaging techniques which present financial and practical challenges
    to
    population-based studies. We assessed whether cardiometabolic
    conditions were associated with VAT by using a new and easily
    measurable anthropometric index previously published and validated.
    Data (1529 participants) came from the European Health Examination
    Survey in Luxembourg (2013–2015). Logistic regressions were used to
    study associations between VAT and cardiometabolic conditions. We
    observed an increased risk of all conditions associated with VAT. The
    total adjusted odds ratio (AOR, [95% CI]) for hypertension, prediabetes/diabetes, hypercholesterolemia, and hypertriglyceridemia
    for the fourth quartile of VAT compared to the lowest were 10.22
    [6.75, 15.47]), (5.90 [4.02, 8.67]), (3.60 [2.47, 5.25]) and (7.67
    [5.04, 11.67]. We observed higher odds in women than in men for all
    outcomes with the exception of hypertension. Future studies should
    investigate the impact of VAT changes on cardiometabolic health and
    the use of anthropometrically predicted VAT as an accurate outcome
    when no biomedical imaging is available.

    Nature Journal link to abstract & article: https://www.nature.com/articles/s41598-021-88587-9

    View the attachments for this post at: http://www.jlaforums.com/viewtopic.php?p=661976512#661976512

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From HeartDoc Andrew@21:1/5 to boldly on Sun Mar 17 21:52:12 2024
    HeartDoc Andrew, in the Holy Spirit, boldly wrote:

    Abstract

    Visceral adiposity is a major risk factor of cardiometabolic
    diseases.
    Visceral adipose tissue (VAT) is usually measured with expensive
    imaging techniques which present financial and practical challenges
    to
    population-based studies. We assessed whether cardiometabolic
    conditions were associated with VAT by using a new and easily
    measurable anthropometric index previously published and validated.
    Data (1529 participants) came from the European Health Examination
    Survey in Luxembourg (2013–2015). Logistic regressions were used to
    study associations between VAT and cardiometabolic conditions. We
    observed an increased risk of all conditions associated with VAT. The
    total adjusted odds ratio (AOR, [95% CI]) for hypertension, >prediabetes/diabetes, hypercholesterolemia, and hypertriglyceridemia
    for the fourth quartile of VAT compared to the lowest were 10.22
    [6.75, 15.47]), (5.90 [4.02, 8.67]), (3.60 [2.47, 5.25]) and (7.67
    [5.04, 11.67]. We observed higher odds in women than in men for all
    outcomes with the exception of hypertension. Future studies should >investigate the impact of VAT changes on cardiometabolic health and
    the use of anthropometrically predicted VAT as an accurate outcome
    when no biomedical imaging is available.

    Nature Journal link to abstract & article: >https://www.nature.com/articles/s41598-021-88587-9


    (VAT) 03/17/24 Again, here's to prevention ...

    https://groups.google.com/g/sci.med.cardiology/c/K0djoxY-NwQ/m/JxflVxU-AgAJ

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From HeartDoc Andrew@21:1/5 to boldly on Mon Mar 18 03:12:23 2024
    HeartDoc Andrew, in the Holy Spirit, boldly wrote:

    Abstract

    Visceral adiposity is a major risk factor of cardiometabolic
    diseases.
    Visceral adipose tissue (VAT) is usually measured with expensive
    imaging techniques which present financial and practical challenges
    to
    population-based studies. We assessed whether cardiometabolic
    conditions were associated with VAT by using a new and easily
    measurable anthropometric index previously published and validated.
    Data (1529 participants) came from the European Health Examination
    Survey in Luxembourg (2013–2015). Logistic regressions were used to
    study associations between VAT and cardiometabolic conditions. We
    observed an increased risk of all conditions associated with VAT. The
    total adjusted odds ratio (AOR, [95% CI]) for hypertension, >prediabetes/diabetes, hypercholesterolemia, and hypertriglyceridemia
    for the fourth quartile of VAT compared to the lowest were 10.22
    [6.75, 15.47]), (5.90 [4.02, 8.67]), (3.60 [2.47, 5.25]) and (7.67
    [5.04, 11.67]. We observed higher odds in women than in men for all
    outcomes with the exception of hypertension. Future studies should >investigate the impact of VAT changes on cardiometabolic health and
    the use of anthropometrically predicted VAT as an accurate outcome
    when no biomedical imaging is available.

    Nature Journal link to abstract & article: >https://www.nature.com/articles/s41598-021-88587-9


    (VAT) 03/18/24 Again, here's to prevention ...

    https://groups.google.com/g/sci.med.cardiology/c/K0djoxY-NwQ/m/JxflVxU-AgAJ

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)